Accord Healthcare Recalls Montelukast Sodium Tablets Due to Manufacturing Deviations
Accord Healthcare recalls approximately 665,469 bottles of Montelukast Sodium 10 mg tablets due to manufacturing process deviations discovered during FDA inspection.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is manufacturing process deviations identified during inspection, which is precautionary in nature rather than a directly identified safety threat.
Plain-English summary
Accord Healthcare, Inc. is recalling approximately 665,469 bottles of Montelukast Sodium Tablets, USP, 10 mg, distributed in the United States (including Puerto Rico) and Canada. The recall affects multiple package sizes: 30-count, 90-count, and 1,000-count bottles.
The recall was initiated following an FDA inspection that identified deviations from current good manufacturing practice (CGMP) standards. CGMP deviations can affect the consistency and quality of the product. No illnesses or injuries related to this product have been reported.
Patients currently taking Montelukast Sodium should consult their healthcare provider before discontinuing the medication. Consumers are advised to return recalled bottles to their pharmacy or contact Accord Healthcare, Inc. for instructions on obtaining replacement product.
The recalled product
- Product
- MONTELUKAST SODIUM (MONTELUKAST SODIUM)
- Brand
- MONTELUKAST SODIUM
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug
- Hazard
- manufacturing-quality
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batches: a) R2000831
- Exp. Date 11/30/2023
- R2000832
- R2200661
- Exp. Date 5/31/2025
- b)R2000836
- R2000837
- R2000838
- R2000840
- R2000842
- R2000835
- R2000841
- R2000833
- R2100310
- R2100311
- R2100314
- R2100312
- R2100313
- R2100315
- R2100316
UPCs (4)
- 0316729119108
- 316729119108
- 316729119153
- 316729119177
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · MONTELUKAST SODIUM
- HighDrug Recall: Montelukast Sodium Tablets Contaminated with Foreign Metoprolol Tablet
FDA (Drugs) · 2023-11-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27